Le Lézard
Classified in: Health
Subject: SVY

Cervical Dysplasia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024


LONDON, May 24, 2018 /PRNewswire/ -- Global Cervical Dysplasia Market: Scope and Methodology
This report on the global cervical dysplasia market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Download the full report: https://www.reportbuyer.com/product/4430756

The research is a combination of primary and secondary research.Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.

Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors.

Growth rates for each segment within the global cervical dysplasia market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cervical cancer market.

Market revenue in terms of US$ Mn for the period between 2017 and 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2024 are provided for all the segments, considering 2016 as the base year.Market size estimations involved in-depth study of services and product features of different types of services.

Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Cervical Dysplasia Market: Segmentation
Based on the diagnosis, the market has been further segmented into two major segments namely, diagnosis tests and diagnostic devices.Diagnosis segment further sub-segmented into Pap smear test, HPV test, and Biopsy.

Moreover, colposcope devices are considered as diagnostic devices for cervical dysplasia market in this report. Based on end user, the market has been segmented into hospitals, diagnostic centers, private gynecological offices, research & academic institutes and ambulatory surgical centers.

Cervical Dysplasia Market: Geographical and Competitive Dynamics
Geographically, the global cervical dysplasia market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.In addition, the regions have been further segmented by major countries from each region.

These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.

The report also profiles major players in the cervical dysplasia market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.Key companies profiled in the report include F.

Hoffmann La-Roche Ltd., QIAGEN, Becton, Dickinson and company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., and Abbott Healthcare Pvt Ltd, exhibit the largest geographical outreach with presence in cervical dysplasia product categories.

The global cervical dysplasia market is segmented as follows:

Global Cervical Dysplasia Market Revenue, by Diagnosis
Diagnosis Test
Pap Smear Test
HPV Test
Biopsy
Diagnostic Device
Colposcopy

Global Cervical Dysplasia Market Revenue, by End User
Hospitals
Diagnostic Centers
Private Gynecologists' Offices
Research & Academic Institutes
Ambulatory Surgical Centers

Global Cervical Dysplasia Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Rest of Middle East & Africa

Download the full report: https://www.reportbuyer.com/product/4430756

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 09:00
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5374, a phase 1/2a study evaluating the safety, tolerability, and antiviral effect of a novel combination regimen that includes...

at 09:00
PureTalk, a nationwide cell phone service provider offering premium wireless service at a fair price on the nation's most dependable 5G network, today celebrates over $100,000 customer donations to the America's Warrior Partnership (AWP). Since...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 09:00
On 5 April 2024, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Board of Directors, with the support of the authorization granted by the annual general meeting held on 17 May 2023, had resolved on a rights issue of units,...

at 09:00
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galentm Breast HER2 has been named a bronze winner of the 2024 Edison Awards in the Diagnostic Technologies category. The awards, named after inventor...

at 09:00
Collective bargaining for registered nurses (RNs) and health-care professionals with the province's for-profit nursing homes has broken down just three days into five days of scheduled negotiations, with no deal reached, says the Ontario Nurses'...



News published on and distributed by: